Our findings provide new insights into the function and molecular pathway to understanding the anti-cancer activity of SFN in GBM cells and support the consideration of SFN as a potent cancer chemopreventive drug candidate for the clinical treatment of GBM. This evidence concerns the gene SFN and cancer.